Autonomix Medical (AMIX) Other financing activities (2023 - 2025)

Autonomix Medical (AMIX) has reported Other financing activities for 3 consecutive years, with $4.5 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Other financing activities fell 99.55% year-over-year to $4.5 in Q4 2025; TTM through Dec 2025 was $11.9 million, a 9.68% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, down 89.88% from the prior year.
• Other financing activities was $4.5 for Q4 2025 at Autonomix Medical, down from $1.1 million in the prior quarter.
• Over five years, Other financing activities peaked at $10.9 million in Q1 2024 and troughed at -$346000.0 in Q4 2023.
• A 3-year average of $2.0 million and a median of $173500.0 in 2023 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities jumped 100.29% in 2024 and tumbled 99.55% in 2025, its largest moves.
• Over 3 years, Other financing activities stood at -$346000.0 in 2023, then jumped by 100.29% to $1000.0 in 2024, then plunged by 99.55% to $4.5 in 2025.
• The last three Other financing activities figures came in at $4.5 (Q4 2025), $1.1 million (Q1 2025), and $1000.0 (Q4 2024), per Business Quant data.